NEW YORK, Sept 29 - SEQUENOM (Nasdaq: SQNM) said Friday it had sold four of its MassArray systems for SNP analysis, bringing the company’s installed commercial base of systems to 16.

Sequenom sold the systems to Hitachi (NYSE: HIT), Genetics Institute, Genaissance Pharmaceuticals (Nasdaq: GNSC) and Integrated DNA Technologies. It did not disclose the terms of the deals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.